Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12616000290493
Ethics application status
Approved
Date submitted
25/02/2016
Date registered
7/03/2016
Date last updated
4/02/2019
Date data sharing statement initially provided
1/02/2019
Date results provided
1/02/2019
Type of registration
Prospectively registered

Titles & IDs
Public title
Pelvic floor assessment in post-partum women
Scientific title
Symptomatic and physiological consequences of obstetric anal sphincter injury in post-partum females
Secondary ID [1] 288626 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Fecal incontinence in post-partum women 297783 0
Obstetric anal sphincter injury syndrome (OASIS) 297828 0
Condition category
Condition code
Oral and Gastrointestinal 297966 297966 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Reproductive Health and Childbirth 297967 297967 0 0
Childbirth and postnatal care

Intervention/exposure
Study type
Observational
Patient registry
True
Target follow-up duration
15
Target follow-up type
Years
Description of intervention(s) / exposure
All participants will be asked to complete a follow up questionnaire.
Anorectal manometry and anorectal ultrasound is to be performed on patient who are consenting to a repeat study using our standard protocol.
(1) Anorectal manometry. This involves insertion of a thin catheter into your rectum (back passage) while you are lying on your left side on a bed. Pressure measurements are then obtained while you squeeze your anal muscles, while you cough and when you bear down or strain. In addition, a small balloon will be inflated inside your rectum and you will be asked to rate the sensations felt at that time. Lastly, you will be requested to try to expel the balloon over a private toilet and (2) Anorectal ultrasound. This involves insertion of an anorectal ultrasound probe into your rectum (back passage) while you are lying on your left side on a bed. Imaging is obtained assessing for your anal sphincters. Both procedures are performed by a physician or a nurse specialist and will be done discretely and with consideration for your privacy at all times. The procedures can cause minor discomfort, but this will be minimised by careful technique. Overall the appointment time is approximately 60 minutes.
The patients invited to participate in this study have previously attended our neurogastroenterology unit for testing between 2001 and 2015. Our follow-up data will consequently offer a follow-up period between 1-15 years.
For ARM testing, the testing protocol is identical to the testing protocol the patients have previously undergone in our Unit. For the anorectal ultrasound, as not all patients have performed this study previously in our Unit, our protocol might be slightly different then the procedure they had previously undergone. Nevertheless, the protocol follows international standards and should be much similiar.
Intervention code [1] 294031 0
Diagnosis / Prognosis
Comparator / control treatment
No control groups
Control group
Uncontrolled

Outcomes
Primary outcome [1] 297489 0
The development of faecal incontinence in previously asymptomatic post-obstetric women with anal sphincter tear. This will be assessed by long term follow up Faecal incontinence severity index (FISI)
Timepoint [1] 297489 0
Patients selected have already completed an anorectal study within our unit at the request of their obstetrician/physician/surgeon between 2001 and 2015. They are invited to complete a follow-up study (identical protocol) to compare data/outcome for this study, hence the follow-up period is anywhere between 1 to 15 years.
Primary outcome [2] 297517 0
The time-related changes in anorectal physiology following OASIS. This will be assessed by the comparing the anorectal physiology parameters (anal pressures) after childbirth to long-term repeated testing.
Timepoint [2] 297517 0
1-15 years following initial assessment
Primary outcome [3] 297518 0
Single component outcome of subsequent birth history(inclduing repeat OASIS) following previous OASIS. This will be assessed by follow up questionnaires specifically designed for the study and access to ObstetriX to obtain the mode and complications of subsequent deliveries.
Timepoint [3] 297518 0
1-15 years following initial assessment
Secondary outcome [1] 321191 0
Change in quality of life following OASIS. This will be assessed by QOL of life questionnaires (SF36, VAS scores)
Timepoint [1] 321191 0
1-15 years following initial assessment
Secondary outcome [2] 321491 0
Outcome in sexual function as assessed by the Sexual Function for Women with: POP, Urinary Incontinence and/or Fecal Incontinence questionnaire.
Timepoint [2] 321491 0
1-15 years following initial assessment

Eligibility
Key inclusion criteria
Post-partum females referred to the Neurogastroenterology Unit for anorectal manometry between 1.1.2001 and 1.1.2016
Minimum age
18 Years
Maximum age
45 Years
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
The only exclusion criterion for the study includes patients with a history of psychological illness or condition such as to interfere with the patient’s ability to understand the requirements of the study.

Only for patients who agree to undergo repeat physiological testing, exclusion criteria include:
1. Women lactating or pregnant.
2. Patients with significant anorectal disease precluding the insertion of an anorectal tube or ultrasound probe.
3. Latex allergy

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis
We will review 450 patients overall, so that we can realistically obtain the 150 patients required to reach statistical power.

9.1 Sample Size Estimation
Aim 1: For quantitative measures a sample of n=144 would provide statistical power of 0.8 and the 0.05 (two-tailed) level of statistical significance for a Cohen’s d effect size of 0.5 (moderate effect size). For qualitative measures a sample of n=92 would provide statistical power of 0.8 and the 0.05 (two-tailed) level of statistical significance for an odds ratio of 2.0 from a baseline probability of 0.3 (overall Fecal Incontinence rate in this group is approximately 1/3).
Aim 2: In aim 2, based entire on unconditional logistic regression (see below), there is an additional consideration of correlation between potential predictors. Defining the minimum clinically important effect size as an odds ratio of 2.0 and assuming a baseline rate of 15%, to allow for a correlation between any predictor and other predictors of 0.3 increases the required sample size from 92 to 149.

Based on this consideration of samples size per aim the expected available sample size (n=150) should exceed the required sample size for all statistical analyses.


9.2 Statistical Analysis Plan
Aim 1: Among women who have undergone Anorectal manometry those who develop Fecal Incontinence will be compared with those who have not developed Fecal Incontinence with respect to quantitative parameters using the Mann-Whitney test and with respect to qualitative parameters via the Pearson Chi-Square test. A nonparametric approach will be adopted due to the expected non-Normal distribution of a number of the quantitative parameters. Identification of statistically independent discriminators of women who develop Fecal Incontinence from those who do not will be via backward elimination within unconditional logistic regression.
Aim 2: All quantitative and qualitative measures utilised in aims 1 which were recorded at the time of OASIS (Obstetric anal sphincter injury syndrome) will be considered as potentially predictive of the development of subsequent pelvic floor complications. The probability of development of pelvic floor complications will be modelled using unconditional logistic regression with predictive variables selected by backward elimination to ensure the full covariance structure of the predictors is taken into account. To protect against the over-optimism phenomenon to which model selection procedures are prone the selection process will itself be bootstrapped (2000 replications) and only predictive measures that are selected in at least 50% of bootstrap samples will be considered in the final predictive model.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
14/03/2016
Actual
1/08/2016
Date of last participant enrolment
Anticipated
30/06/2018
Actual
30/06/2018
Date of last data collection
Anticipated
30/06/2018
Actual
19/12/2018
Sample size
Target
450
Accrual to date
Final
249
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 5351 0
Royal North Shore Hospital - St Leonards
Recruitment postcode(s) [1] 12805 0
2065 - Royal North Shore Hospital

Funding & Sponsors
Funding source category [1] 292985 0
Self funded/Unfunded
Name [1] 292985 0
Dr Allison Malcolm Research Fund
Country [1] 292985 0
Australia
Primary sponsor type
Individual
Name
Dr Allison Malcolm
Address
Royal North Shore Hospital
Neurogastroenterology Unit
Reserve Road
St-Leonards, NSW 2065
Country
Australia
Secondary sponsor category [1] 291756 0
None
Name [1] 291756 0
n/a
Address [1] 291756 0
n/a
Country [1] 291756 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 294494 0
Northern Sydney Local Health District
Ethics committee address [1] 294494 0
Ethics committee country [1] 294494 0
Australia
Date submitted for ethics approval [1] 294494 0
14/12/2015
Approval date [1] 294494 0
10/02/2016
Ethics approval number [1] 294494 0
HREC/15/HAWKE/486

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 63906 0
Dr Allison Malcolm
Address 63906 0
Royal North Shore Hospital
Neurogastroenterology Unit
Reserve Road
St-Leonards, NSW 2065
Country 63906 0
Australia
Phone 63906 0
+61(0)294632450
Fax 63906 0
Email 63906 0
[email protected]
Contact person for public queries
Name 63907 0
Allison Malcolm
Address 63907 0
Royal North Shore Hospital
Neurogastroenterology Unit
Reserve Road
St-Leonards, NSW 2065
Country 63907 0
Australia
Phone 63907 0
+61(0)294632450
Fax 63907 0
Email 63907 0
[email protected]
Contact person for scientific queries
Name 63908 0
Allison Malcolm
Address 63908 0
Royal North Shore Hospital
Neurogastroenterology Unit
Reserve Road
St-Leonards, NSW 2065
Country 63908 0
Australia
Phone 63908 0
+61(0)294632450
Fax 63908 0
Email 63908 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
As per ethics approval, raw data will only be accessible by the investigators


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.